Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Nephron Sterile Compounding Center LLC
483
•Nephron Sterile Compounding Center LLC•April 21, 2017

Nephron Sterile Compounding Center LLC – FDA 483, Apr 21, 2017

Record Details

On April 21, 2017, the FDA issued a Form 483 to Nephron Pharmaceuticals Corporation, an outsourcing facility located in West Columbia, SC, following an inspection from April 17-21, 2017. The inspection identified four observations related to laboratory control, quality systems, and packaging/labeling.

**Laboratory Control System:** 1. **Sterilization Process Validation:** The firm failed to adequately validate the sterilization process for sterile drug products. Specifically, aseptic process simulations were not performed to validate the Phenylephrine Hydrochloride aseptic sterilization process, failing to assure sterility throughout the process. 2. **Test Procedures and Visual Inspection:** Laboratory controls lacked scientifically sound and appropriate test procedures. * The "Visual Inspection of Compounded Sterile Preparations" procedure (SQE.OC A30L, version 1.0) and operators performing 100% visual inspection lacked a representative library of potential defects for training and qualification. * The firm had not defined defect categories for visual inspections or performed trending of such defects for continuous process quality improvements.

**Quality System:** 3. **Quality Control Unit Procedures:** Responsibilities and procedures of the quality control unit were not fully followed. The firm had not established a required element of its Quality Program, with reviews not being conducted as per SOP.

**Packaging and Labeling System:** 4. **Container Label Deficiencies

Company
Nephron Sterile Compounding Center LLC
Inspection date
April 21, 2017
Product type
Drugs
Office
Atlanta District Office
People
  • Rachael L. Cook (Investigator)
  • Bonita S. Chester (Director of Inspection Readiness)
  • Diane P. Goyette (Senior Advisor)
View Company Profile

ID · 5f17ae1c-a089-4536-8e06-5c61164a98cd

Violation Codes1
21 CFR 331(c)

Full citation text and observation details available on the Dashboard.

Other documents for Nephron Sterile Compounding Center LLC
  • 483 - 2024-09-25September 25, 2024
  • 483 - 2023-02-10February 10, 2023
  • 483 - 2022-04-20April 20, 2022
  • 483 - 2019-11-15November 15, 2019
  • 483 - 2018-04-20April 20, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nephron Sterile Compounding Center LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.